Does OBINUTUZUMAB Cause Febrile neutropenia? 955 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 955 reports of Febrile neutropenia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 6.7% of all adverse event reports for OBINUTUZUMAB.
955
Reports of Febrile neutropenia with OBINUTUZUMAB
6.7%
of all OBINUTUZUMAB reports
91
Deaths
473
Hospitalizations
How Dangerous Is Febrile neutropenia From OBINUTUZUMAB?
Of the 955 reports, 91 (9.5%) resulted in death, 473 (49.5%) required hospitalization, and 61 (6.4%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
Atrial fibrillation (548)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which OBINUTUZUMAB Alternatives Have Lower Febrile neutropenia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE